Mucormycosis in COVID-19 recovered patients.

Kumar, Anoop

Kumar, Anoop.

Kumar A; Department of Pharmacology, Delhi Pharmaceutical Sciences & Research University (DPSRU), New Delhi, India.

J Med Virol ; 94(4): 1272-1273, 2022 Apr.

Article in English | MEDLINE | ID: covidwho-1568206

Subject(s)

COVID-19/complications; Mucormycosis/etiology; COVID-19/therapy; Early Diagnosis; Humans; Mucormycosis/diagnosis; Mucormycosis/therapy; Respiration, Artificial/adverse effects; Risk Factors; SARS-CoV-2; Steroids/administration & dosage; Steroids/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Mucormycosis Type of study: Diagnostic study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Med Virol Year: 2022 Document Type: Article Affiliation country: Jmv.27522

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google